Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission

European Journal of Pharmacology

Volumn 453, Issue 2-3, 2002, Pages 223-229

  Deslandes, Paul N ^a   Pache, David M ^a   Buckland, Paul ^b   Sewell, Robert D E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) reuptake inhibitor, selective; Cocaine; Conditioned place preference; Dopamine; HPLC (High performance liquid chromatography); Morphine; Radioligand binding

Indexed keywords

ANTIDEPRESSANT AGENT; CHEMICAL COMPOUND; COCAINE; DOPAMINE RECEPTOR; DRUG METABOLITE; MORPHINE; PAROXETINE; RADIOLIGAND; SERTRALINE; 3,4 DIHYDROXYPHENYLACETIC ACID; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR; HOMOVANILLIC ACID; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISSECTION; DOPAMINERGIC NERVE CELL; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG WITHDRAWAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MESENCEPHALON; MOTIVATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; ANIMAL; COMPARATIVE STUDY; CONDITIONING; METABOLISM; RADIOASSAY; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; MESENCEPHALON; MORPHINE; MOTIVATION; NUCLEUS ACCUMBENS; PAROXETINE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0037174821     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02451-2     Document Type: Article

References (43)

1. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
2. 3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. J. Pharmacol. Exp. Ther. 252:1990;901-907.
3. 3 receptors in rat striatum. J. Phamacol. Exp. Ther. 251:1989;803-809.
4. Bolden-Watson C., Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52:1993;1023-1029.
5. 3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system. Eur. J. Pharmacol. 167:1989;299-303.
6. Di Chiara G., Imperato A. Opposite effects of Mu and Kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1987;1067-1080.
7. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5274-5278.
8. Di Mascio M., Di Giovanni G., Di Matteo V., Prisco S., Esposito E. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Brain Res. Bull. 46:1998;547-554.
9. Ghosh S., Patel A.H., Cousins M., Grasing K. Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens. Neurochem. Res. 23:1998;875-885.
10. Haddad P. The SSRI discontinuation syndrome. J. Psychopharmacol. 12:1998;305-313.
11. 1 receptor binding and apomorphine effects in the rat. J. Psychopharmacol., Suppl. A. 39:1997;154.
12. 1 dopamine receptor. Biochem. Pharmacol. 44:1992;325-334.
13. Ichikawa J., Kuroki T., Meltzer H.Y. Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens. Eur J. Pharmacol. 350:1998;159-164.
14. Imperato A., Mele A., Scrocco M.G., Puglisi-Allegra S. Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur. J. Pharmacol. 212:1992;299-300.
15. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
16. King G.R., Kuhn C., Ellinwood E.H. Jr. Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology. 111:1993;179-184.
17. 2 dopamine receptors in rat brain. Brain Res. 532:1990;265-270.
18. 3H]SCH 23390 binding sites in the rat striatum and limbic system. Eur. J. Pharmacol. 139:1987;163-169.
19. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
20. Kuhar M.J., Pilotte N.S. Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 17:1996;260-264.
21. Leone P., Di Chiara G. Blockade of D-1 receptors by SCH 23390 antagonizes morphine-and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135:1987;251-254.
22. 1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573:1992;331-335.
23. Much R.F., Van De Kooy D., O'Shaughnessy M., Bucenieks P. Drug reinforcement studied by the use of place preference conditioning in rat. Brain Res. 243:1982;91-105.
24. Papp M. Different effect of short and long term treatment with imipramine on the apomorphine and food induced place preference conditioning in rat. Pharmacol. Biochem. Behav. 30:1988;889-893.
25. Papp M. Differential effects of short and long term antidepressant treatments on the food induced place preference conditioning in rats. Behav. Pharmacol. 1:1989;69-74.
26. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Pschopharmacology. 115:1994;441-446.
27. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
28. Piepponen T.P., Ahtee L. Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism. Pharmacol. Toxicol. 77:1995;204-208.
29. Pothos E., Rada P., Mark G.P., Hoebel B.G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566:1991;348-350.
30. Prisco S., Esposito E. Differential effects of acute and chronic floxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br. J. Pharmacol. 116:1995;1923-1931.
31. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271:1994;83-90.
32. Rafieian-Kopeai M., Gray A.M., Spencer P.S.J., Sewell R.D.E. Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. Eur. J. Pharmacol. 275:1995;185-189.
33. Reith M.E.A., Li M.-Y., Yan Q.-S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology. 134:1997;309-317.
34. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
35. Rossetti Z.L., Hmaidan Y., Gessa G.L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221:1992;227-234.
36. Shippenberg T.S., Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151:1988;233-242.
37. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
38. Spanagel R., Herz A., Shippenberg T.S. Identification of the opioid receptor types mediating β-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Phamacol. 190:1990;177-184.
39. Spyraki C., Fibiger H.C., Phillips A.G. Cocaine-induced place conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 253:1982;195-203.
40. Strange P.G., Williamson R.A. Dopamine receptors: isolation and molecular characterization. Hulme E.C. Receptor Biochemistry. 1993;79-97 IRL Press, Oxford, UK.
41. Subhan F., Pache D.M., Spencer P.S.J., Sewell R.D.E. Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine. Eur. J. Pharmacol. 390:2000;137-143.
42. Subhan F., Deslandes P.N., Pache D.M., Sewell R.D.E. Do antidepressants affect motivation in conditioned place preference? Eur. J. Pharmacol. 408:2000;257-263.
43. Zeigler S., Lipton J., Toga A., Ellison G. Continuous cocaine administration produces persisting changes in neurochemistry and behavior. Brain Res. 552:1991;27-35.